Paratek Pharmaceuticals, Inc. announced that Douglas Pagán, Chief Financial Officer, has resigned, effective April 5, 2019, to join an early-stage biopharmaceutical company. He has entered into a consulting agreement with the company through December 23, 2019 to assist the company in the orderly transition of his Chief Financial Officer responsibilities. The company has initiated a search to identify and recruit a new candidate for the role of Chief Financial Officer.

The company also announced that Sarah Higgins, the company's Vice President and Controller, will serve as the company's Principal Financial Officer and Principal Accounting Officer as the company conducts a search for a new Chief Financial Officer.